Alpha Tau Medical (DRTS) Cash from Financing Activities (2021 - 2022)
Alpha Tau Medical's (DRTS) quarterly Cash from Financing Activities came in at $14.8 million in Q2 2022, down 81.93% quarter-over-quarter from $82.0 million in Q1 2022.
Alpha Tau Medical (DRTS) Cash from Financing Activities (2021 - 2022) Analysis & Trends
Alpha Tau Medical has disclosed Cash from Financing Activities across 2 years of filings, most recently posting $14.8 million for Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 7.00 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -600,000.00 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 53,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -538.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 85,464.43 |
| 10 | Alpha Tau Medical | 2,416.70 | -76.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 14.82 Mn |
| Jun 30, 2022 | 14.82 Mn |
| Mar 31, 2022 | 81.99 Mn |
| Mar 31, 2022 | 81.99 Mn |
| Mar 31, 2021 | 1,000.00 |
| Mar 31, 2021 | 1,000.00 |